EU/3/14/1405

About

Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2019 on request of the sponsor.

On 16 December 2014, orphan designation (EU/3/14/1405) was granted by the European Commission to TxCell, France, for autologous collagen type II-specific regulatory T cells for the treatment of non-infectious uveitis.

Key facts

Active substance
Autologous collagen type II-specific regulatory T cells
Disease / condition
Treatment of non-infectious uveitis
Date of first decision
16/12/2014
Outcome
Withdrawn
EU designation number
EU/3/14/1405

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

TxCell
Allée de la Nertière - Les Cardoulines
06560 Valbonne - Sophia Antipolis
France
Tel. +33 497 21 83 01
Fax +33 493 64 15 80
E-mail: contact@txcell.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;

How useful was this page?

Add your rating